These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approaches. Kadakia MB; Herrmann HC; Desai ND; Fox Z; Ogbara J; Anwaruddin S; Jagasia D; Bavaria JE; Szeto WY; Vallabhajosyula P; Li R; Menon R; Kobrin DM; Giri J Circ Cardiovasc Interv; 2014 Aug; 7(4):570-6. PubMed ID: 25027520 [TBL] [Abstract][Full Text] [Related]
14. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Van Mieghem NM; Tchetche D; Chieffo A; Dumonteil N; Messika-Zeitoun D; van der Boon RM; Vahdat O; Buchanan GL; Marcheix B; Himbert D; Serruys PW; Fajadet J; Colombo A; Carrié D; Vahanian A; de Jaegere PP Am J Cardiol; 2012 Nov; 110(9):1361-7. PubMed ID: 22819428 [TBL] [Abstract][Full Text] [Related]
15. Vascular access site complications after transfemoral transcatheter aortic valve implantation in the POL-TAVI Registry: surgical versus percutaneous approach. Walas RL; Kukulski L; Rychter J; Jaźwiec T; Gąska M; Hawranek M; Zembala M; Gąsior M; Zembala MO J Cardiovasc Surg (Torino); 2020 Feb; 61(1):117-122. PubMed ID: 31815374 [TBL] [Abstract][Full Text] [Related]
16. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation. Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436 [TBL] [Abstract][Full Text] [Related]
17. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034 [TBL] [Abstract][Full Text] [Related]
18. Transcatheter aortic valve implantation using a direct aortic approach: a single-centre Heart Team experience. Amrane H; Porta F; van Boven AJ; Boonstra PW; Hofma SH; Head SJ; Kappetein AP Interact Cardiovasc Thorac Surg; 2014 Nov; 19(5):777-81. PubMed ID: 25074233 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial. Durand E; Le Breton H; Lefevre T; Gilard M; Himbert D; Alcazar MU; Bettinger N; Auffret V; Didier R; Chevalier B; Béziau DM; Iung B; Eltchaninoff H Arch Cardiovasc Dis; 2020; 113(6-7):391-400. PubMed ID: 32418883 [TBL] [Abstract][Full Text] [Related]
20. Surgical cutdown versus percutaneous access in transfemoral transcatheter aortic valve implantation: Insights from the Brazilian TAVI registry. Bernardi FL; Gomes WF; de Brito FS; Mangione JA; Sarmento-Leite R; Siqueira D; Carvalho LA; Tumelero R; Guerios EE; Lemos PA Catheter Cardiovasc Interv; 2015 Sep; 86(3):501-5. PubMed ID: 25586633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]